Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.64 |
| ▸ | MEN1 | O00255 | 3/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 2/20 | 0.57 |
| ▸ | RAB9A | P51151 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5463769 | 0.81 | MEN1 (0.64) | LMNAKMT2AMEN1L3MBTL1SMN1; SMN2 | |
| SCHEMBL5449341 | 0.78 | ALDH1A1 (0.70) | LMNAKMT2AMEN1L3MBTL1NPC1 | |
| SCHEMBL29838503 | 0.78 | ALDH1A1 (0.70) | LMNAKMT2AMEN1L3MBTL1NPC1 | |
| SCHEMBL3065751 | 0.78 | KMT2A (1.00) | LMNAKMT2AMEN1SMN1; SMN2MAPT | |
| SCHEMBL5450015 | 0.78 | ALDH1A1 (0.73) | LMNAKMT2AMEN1L3MBTL1NPC1 | |
| SCHEMBL1647857 | 0.78 | ALDH1A1 (0.69) | LMNAKMT2AMEN1NPC1RAB9A | |
| SCHEMBL29000353 | 0.77 | KMT2A (0.59) | LMNAKMT2AMEN1MAPTALDH1A1 | |
| SCHEMBL28820782 | 0.77 | KMT2A (0.64) | LMNAKMT2AMEN1RAB9ASMN1; SMN2 | |
| SCHEMBL11803606 | 0.77 | NPC1 (0.69) | LMNAKMT2AMEN1L3MBTL1NPC1 | |
| SCHEMBL5450433 | 0.76 | KMT2A (0.58) | LMNAKMT2AMEN1L3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260128361-A1 | FUNCTIONAL ALIPHATIC AND/OR AROMATIC AMINE COMPOUNDS OR DERIVATIVES AS ELECTROLYTE ADDITIVES TO REDUCE GAS GENERATION IN LI-ION BATTERIES | ENEVATE CORP (US) | 2026-05-07 | — | — | US | disclosed |
| US-12438181-B2 | Functional aliphatic and/or aromatic amine compounds or derivatives as electrolyte additives to reduce gas generation in Li-ion batteries | ENEVATE CORPORATION (US) | 2025-10-07 | — | — | US | disclosed |
| US-20210328256-A1 | FUNCTIONAL ALIPHATIC AND/OR AROMATIC AMINE COMPOUNDS OR DERIVATIVES AS ELECTROLYTE ADDITIVES TO REDUCE GAS GENERATION IN LI-ION BATTERIES | ENEVATE CORPORATION | 2021-10-21 | — | — | US | disclosed |
| US-20210328256-A1 | FUNCTIONAL ALIPHATIC AND/OR AROMATIC AMINE COMPOUNDS OR DERIVATIVES AS ELECTROLYTE ADDITIVES TO REDUCE GAS GENERATION IN LI-ION BATTERIES | ENEVATE CORPORATION | 2021-10-21 | — | — | US | disclosed |
| WO-2021194742-A1 | FUNCTIONAL ALIPHATIC AND/OR AROMATIC AMINE COMPOUNDS OR DERIVATIVES AS ELECTROLYTE ADDITIVES TO REDUCE GAS GENERATION IN LI-ION BATTERIES | ENEVATE CORPORATION (US) | 2021-09-30 | — | — | WO | disclosed |
| WO-2021194742-A1 | FUNCTIONAL ALIPHATIC AND/OR AROMATIC AMINE COMPOUNDS OR DERIVATIVES AS ELECTROLYTE ADDITIVES TO REDUCE GAS GENERATION IN LI-ION BATTERIES | ENEVATE CORPORATION (US) | 2021-09-30 | — | — | WO | disclosed |
| US-11018371-B1 | Functional aliphatic and/or aromatic amine compounds or derivatives as electrolyte additives to reduce gas generation in li-ion batteries | ENEVATE CORPORATION (US) | 2021-05-25 | — | — | US | disclosed |
| US-11018371-B1 | Functional aliphatic and/or aromatic amine compounds or derivatives as electrolyte additives to reduce gas generation in li-ion batteries | ENEVATE CORPORATION (US) | 2021-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260128361-A1 | FUNCTIONAL ALIPHATIC AND/OR AROMATIC AMINE COMPOUNDS OR DERIVATIVES AS ELECTROLYTE ADDITIVES TO REDUCE GAS GENERATION IN LI-ION BATTERIES | LAGE3, ROS1, CACNA2D3 | LMNA 1254/4885KMT2A 811/4885MEN1 4270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.